good sense naproxen sodium

Product NDC: 0113-8264
11-digit product format: 001138264
Labeler code: 0113
Product ID: 0113-8264_2d70302c-e43d-4422-a002-57505904f605
Type: HUMAN OTC DRUG
Nonproprietary name: diphenhydramine hydrochloride, naproxen sodium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: L. Perrigo Company
Application: ANDA208499
Marketing category: ANDA
Marketing start: 2018-12-28
Substance: DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Active strength: 25; 220 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0113-8264	0113-8264-58	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25MG;220MG	TABLET / ORAL			2019-05-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A208499-001	NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE	25MG;220MG	TABLET / ORAL	2019-05-10	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: good sense naproxen sodium
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DIPHENHYDRAMINE HYDROCHLORIDE	25 mg/1
NAPROXEN SODIUM	220 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
TC2D6JAD40	Internal UNII lookup
9TN87S3A3C	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1550957	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f548aa3d-b35e-458a-9815-3595a451ab78	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fef6ad89-235f-4274-ba49-a8e53642473e	Product name	2	20250225
0e2e0f88-b076-afe1-4bdd-32bca4375bec	Product name	3	20250127
87fed3e6-8fba-48ef-96b0-3a7fb54b96ff	Product name	3	20230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8	Product name	1	20200623
e76dbbc1-775d-722c-08ff-ed45e8a80def	Product name	3	20181002
3e48c9c4-918d-5d23-2f0b-d2398b06be54	Product name	1	20140508
6f4f4521-fd56-1ae6-888b-3b021bd75c7c	Product name	1	20140508
865c72dd-0d94-daac-f728-ddd4ded2a79e	Product name	1	20140508
ce67e27d-1d21-5465-4409-b0662dd99d4d	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0113-8264-00	good sense naproxen sodium	160 in 1 BOTTLE	TABLET, FILM COATED	160	7
0113-8264-06	good sense naproxen sodium	1 in 1 CARTON	TABLET, FILM COATED	1	7
0113-8264-58	good sense naproxen sodium	40 in 1 BOTTLE	TABLET, FILM COATED	40	7
0113-8264-58	good sense naproxen sodium	1 in 1 CARTON	TABLET, FILM COATED	1	7
0113-8264-60	good sense naproxen sodium	1 in 1 CARTON	TABLET, FILM COATED	1	7
0113-8264-60	good sense naproxen sodium	20 in 1 BOTTLE	TABLET, FILM COATED	20	7
0113-8264-71	good sense naproxen sodium	1 in 1 CARTON	TABLET, FILM COATED	1	7
0113-8264-71	good sense naproxen sodium	50 in 1 BOTTLE	TABLET, FILM COATED	50	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0113-8264-58	EA - Each	0113-8264	cc3fc1b7-de81-431d-a863-f08e085806fd	1	2022-05-04
0113-8264-60	EA - Each	0113-8264	e8ee7044-c69a-4bec-b685-bf4f779f4ccc	1	2022-05-04
0113-8264-71	EA - Each	0113-8264	a1a7bc1b-803a-444d-9ebc-4ff9d33602b8	1	2024-02-14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0113-8264	GOOD SENSE NAPROXEN SODIUM (DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM) TABLET, FILM COATED [L. PERRIGO COMPANY]	5	Current NDC, Legacy NDC, 8 package rows	20230812_f548aa3d-b35e-458a-9815-3595a451ab78.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Meijer Distribution Inc	34d635f8-9703-4c29-92a5-85d3b47c4c93	2026-07-07	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
good sense naproxen sodium	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	L. Perrigo Company	f548aa3d-b35e-458a-9815-3595a451ab78	2026-05-11	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499 ndc (product): 0113-8264
ALL NIGHT PAIN RELIEF PM	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Walgreen Company	43e4ed28-b1be-4548-86ac-f40f9f83f04e	2026-04-27	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	H E B	4281faf5-7182-404f-9f53-3d9ea0354a18	2026-02-12	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
topcare all night pain relief pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Topco Associates LLC	a20f193e-4e64-400a-b605-df08026cb80b	2025-12-11	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
up and up naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Target Corporation	c0769941-bcf2-4237-b70c-a79089ad5335	2025-11-05	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
dg health naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Dolgencorp Inc	6c2c087c-e36d-4971-b977-d3cab6d6edee	2025-11-05	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Kroger Company	d5dafdd0-968d-4ee6-9461-1f72d3255240	2025-07-10	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
NAPROXEN SODIUM PM	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Safeway	60cb7b6e-f2d2-48ca-8db7-7124717735d5	2025-07-09	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
equaline naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	United Natural Foods, Inc. dba UNFI	ed7bfa3f-4972-4ab6-9f0c-0873a11571a9	2025-06-04	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
basic care naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	Amazon.com Services LLC	7beed9e7-816b-494b-93fa-9caf10aa3834	2024-01-24	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499
careone naproxen sodium pm	DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM	American Sales Company	16547905-59c0-4936-82e1-2d9f5935d8dd	2023-12-11	Warnings	Exact identifier application applno (ANDA): 208499 application number: ANDA208499

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
TC2D6JAD40	DIPHENHYDRAMINE HYDROCHLORIDE	147-24-0	DIPHENHYDRAMINE HYDROCHLORIDE
9TN87S3A3C	NAPROXEN SODIUM	26159-34-2	NAPROXEN SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1550957	diphenhydrAMINE HCl 25 MG / naproxen sodium 220 MG Oral Tablet	PSN	f548aa3d-b35e-458a-9815-3595a451ab78	7
1550957	diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet	SCD	f548aa3d-b35e-458a-9815-3595a451ab78	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0113-8264-00	00113826400	160 in 1 BOTTLE						Historical
0113-8264-06	00113826406	1 BOTTLE in 1 CARTON (0113-8264-06) / 160 TABLET, FILM COATED in 1 BOTTLE (0113-8264-00)	1 bottle	2026-02-26		No	No	Current
0113-8264-58	00113826458	1 BOTTLE in 1 CARTON (0113-8264-58) > 40 TABLET, FILM COATED in 1 BOTTLE	1 bottle	2019-06-06	0000-00-00	No	No	Current
0113-8264-60	00113826460	1 BOTTLE in 1 CARTON (0113-8264-60) / 20 TABLET, FILM COATED in 1 BOTTLE	1 bottle	2018-12-28	0000-00-00	No	No	Current
0113-8264-71	00113826471	1 BOTTLE in 1 CARTON (0113-8264-71) / 50 TABLET, FILM COATED in 1 BOTTLE	1 bottle	2022-03-14	0000-00-00	No	No	Current